1-3 of 3
Oscar Garces
Close
Sort by
Journal Articles

Primary Prophylaxis Using Peg-Filgrastim Is Useful Preventing Severe Infections and Neutropenia in Patients Diagnosed with Non Hodgkin Lymphoma (NHL). Report of Latin America International Multicenter Study

Luis Villela, MD, Alberto Villalobos, MD, Gustavo Reyes-Brena, MD, Jorge Duque, MD, Juan Carlos Solís-Poblano, Eduardo Reynoso, MD, Roberto Ovilla, MD, Alejandro Camacho, MD, Norberto Vazquez, MD, Oscar Garces, Enrique Pedrasa, MD, Salvador Silva, MD
Journal: Blood
Blood (2008) 112 (11): 4663.
https://doi.org/10.1182/blood.V112.11.4663.4663
Published: 2008
Journal Articles

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

Silvia Rivas-Vera, MD, Enrique Baez, MD, Pedro Sobrevilla-Calvo, MD, Severiano Baltazar, MD, Francisco Tripp, MD, Jorge Vela, MD, Oscar Garces, MD, Luis Aguilar, MD, Gregorio Ignacio, MD, Jorge Duque, MD, Petty Rodriguez, MD, Gustavo Reyes, MD
Journal: Blood
Blood (2005) 106 (11): 2431.
https://doi.org/10.1182/blood.V106.11.2431.2431
Published: 2005
Journal Articles

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Rosa M. Arana, QFB, Pedro Sobrevilla-Calvo, MD, Silvia Rivas-Vera, MD, Enrique Baez, MD, Severiano Baltazar, MD, Jorge Duque, MD, Ignacio Gregorio, MD, Francisco Tripp, MD, Oscar Garces, MD, Luis Aguilar, MD, Luis Flores, MD
Journal: Blood
Blood (2005) 106 (11): 4493.
https://doi.org/10.1182/blood.V106.11.4493.4493
Published: 2005